Skip to ContentSkip to Navigation
Practical matters How to find us prof. dr. E.M.D. (Ed) Schuuring


A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice

A novel PPP2R2A::PRKD1 fusion in a cribriform adenocarcinoma of salivary gland

Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting

Optimalisatie van de zorgketen moleculaire diagnostiek bij niet-kleincellig longcarcinoom in Noord-Nederland

The effect of extended participation windows on attendance at cervical cancer screening

Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)

Using genomic scars to select immunotherapy beneficiaries in advanced non-small cell lung cancer

Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature

Age-specific oncogenic pathways in head and neck squamous cell carcinoma - are elderly a different subcategory?

Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non-Small-Cell Lung Cancer in the Netherlands

Read more


Doelgerichte therapie bij longkanker

Naar een heel nieuw systeem voor kankerzorg en -diagnostiek

Commissie Beoordeling Diagnostiek

Organisatie moleculaire diagnostiek bij mammacarcinoom

At ESMO, Focusing on Non-Small Cell Lung Cancer

Longkanker: welke vorm heb ik?

25 jaar Moleculaire Diagnostiek binnen de Pathologie in Nederland

Moleculaire diagnostiek volop in beweging

“Betere diagnostiek verhoogt overlevingskans”

Read more